Iovance Biotherapeutics aims to be the global leader in innovating developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy including gene-edited cell therapy which may be a promising option for patients with cancer. Overview The Associate Director Digital Experience & AI Production owns how Iovance’s external digital presence gets produced published found and kept accurate across web visual assets search and measurement. Working at the intersection of … Sign In to View